MarketCap
Facebook
X
TelegramAnnual report 2024
added 02-27-2025
ACADIA Pharmaceuticals Total Inventories 2011-2026 | ACAD
Annual Total Inventories ACADIA Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91.7 M | 40.4 M | - | 14.1 M | 9.68 M | 6.34 M | 4.07 M | 5.25 M | 4.18 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 91.7 M | 4.07 M | 22 M |
Quarterly Total Inventories ACADIA Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 M | 11.6 M | - | 12.5 M | 13.2 M | 14.1 M | 14.3 M | 10.8 M | 10.3 M | 9.68 M | 9.68 M | 9.68 M | 9.68 M | 6.34 M | 6.34 M | 6.34 M | 6.34 M | 4.07 M | 4.07 M | 4.07 M | 4.07 M | 5.25 M | 5.25 M | 5.25 M | 5.25 M | 4.18 M | 4.18 M | 4.18 M | 4.18 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.3 M | 4.07 M | 7.71 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 21.65 | 1.12 % | $ 1.01 B |  USA |
 |
Aptorum Group Limited
APM
|
39.1 K | $ 0.9 | -0.18 % | $ 6.62 M |  China |
 |
Heron Therapeutics
HRTX
|
92.7 M | - | - | $ 198 M | USA |
 |
ImmuCell Corporation
ICCC
|
9.27 M | $ 8.25 | -1.26 % | $ 74.5 M | USA |
 |
Jaguar Health
JAGX
|
8.6 M | $ 0.28 | -27.77 % | $ 653 K | USA |
 |
KalVista Pharmaceuticals
KALV
|
3.43 M | $ 19.16 | -2.39 % | $ 1.03 B |  Britain |
 |
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.1 | 0.49 % | $ 438 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 23.42 | 0.69 % | $ 2.98 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.42 | -1.39 % | $ 378 M | Britain |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
14.1 M | $ 241.79 | 4.55 % | $ 4.42 B | USA |
 |
Eli Lilly and Company
LLY
|
13.7 B | - | - | $ 783 B | USA |
 |
Esperion Therapeutics
ESPR
|
105 M | - | - | $ 399 M | USA |
 |
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | USA |
 |
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B |  Cayman-islands |